These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 22991317)
1. Two forms of iron as an intrinsic contrast agent in the basal ganglia of PKAN patients. Dezortova M; Herynek V; Krssak M; Kronerwetter C; Trattnig S; Hajek M Contrast Media Mol Imaging; 2012; 7(6):509-15. PubMed ID: 22991317 [TBL] [Abstract][Full Text] [Related]
2. MR relaxometry and 1H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients. Hájek M; Adamovicová M; Herynek V; Skoch A; Jírů F; Krepelová A; Dezortová M Eur Radiol; 2005 May; 15(5):1060-8. PubMed ID: 15565311 [TBL] [Abstract][Full Text] [Related]
3. Nigropallidal iron accumulation in pantothenate kinase-associated neurodegeneration demonstrated by susceptibility-weighted imaging. Lee JH; Kim DS; Baik SK; Nam SO J Neurol; 2010 Apr; 257(4):661-2. PubMed ID: 19967543 [No Abstract] [Full Text] [Related]
4. Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration. Santambrogio P; Ripamonti M; Paolizzi C; Panteghini C; Carecchio M; Chiapparini L; Raimondi M; Rubio A; Di Meo I; Cozzi A; Taverna S; De Palma G; Tiranti V; Levi S Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456086 [TBL] [Abstract][Full Text] [Related]
5. Involvement of globus pallidus and midbrain nuclei in pantothenate kinase-associated neurodegeneration: measurement of T2 and T2* time. Fermin-Delgado R; Roa-Sanchez P; Speckter H; Perez-Then E; Rivera-Mejia D; Foerster B; Stoeter P Clin Neuroradiol; 2013 Mar; 23(1):11-5. PubMed ID: 22258188 [TBL] [Abstract][Full Text] [Related]
6. Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus. Woltjer RL; Reese LC; Richardson BE; Tran H; Green S; Pham T; Chalupsky M; Gabriel I; Light T; Sanford L; Jeong SY; Hamada J; Schwanemann LK; Rogers C; Gregory A; Hogarth P; Hayflick SJ Mol Genet Metab; 2015 Dec; 116(4):289-97. PubMed ID: 26547561 [TBL] [Abstract][Full Text] [Related]
7. Skin fibroblasts from pantothenate kinase-associated neurodegeneration patients show altered cellular oxidative status and have defective iron-handling properties. Campanella A; Privitera D; Guaraldo M; Rovelli E; Barzaghi C; Garavaglia B; Santambrogio P; Cozzi A; Levi S Hum Mol Genet; 2012 Sep; 21(18):4049-59. PubMed ID: 22692681 [TBL] [Abstract][Full Text] [Related]
8. Diffusion tensor MR imaging in children with pantothenate kinase-associated neurodegeneration with brain iron accumulation and their siblings. Awasthi R; Gupta RK; Trivedi R; Singh JK; Paliwal VK; Rathore RK AJNR Am J Neuroradiol; 2010 Mar; 31(3):442-7. PubMed ID: 19850762 [TBL] [Abstract][Full Text] [Related]
9. Measurement of brain iron distribution in Hallevorden-Spatz syndrome. Szumowski J; Bas E; Gaarder K; Schwarz E; Erdogmus D; Hayflick S J Magn Reson Imaging; 2010 Feb; 31(2):482-9. PubMed ID: 20099363 [TBL] [Abstract][Full Text] [Related]
10. Missense PANK2 mutation without "eye of the tiger" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN). Delgado RF; Sanchez PR; Speckter H; Then EP; Jimenez R; Oviedo J; Dellani PR; Foerster B; Stoeter P J Magn Reson Imaging; 2012 Apr; 35(4):788-94. PubMed ID: 22127788 [TBL] [Abstract][Full Text] [Related]
11. Basal ganglia calcification in a case of PKAN. Fasano A; Shahidi G; Lang AE; Rohani M Parkinsonism Relat Disord; 2017 Mar; 36():98-99. PubMed ID: 28024710 [No Abstract] [Full Text] [Related]
12. Magnetic resonance imaging, susceptibility weighted imaging and quantitative susceptibility mapping findings of pantothenate kinase-associated neurodegeneration. Zeng J; Xing W; Liao W; Wang X J Clin Neurosci; 2019 Jan; 59():20-28. PubMed ID: 30392836 [TBL] [Abstract][Full Text] [Related]
13. Transcranial sonography in pantothenate kinase-associated neurodegeneration. Kostić VS; Svetel M; Mijajlović M; Pavlović A; Ječmenica-Lukić M; Kozić D J Neurol; 2012 May; 259(5):959-64. PubMed ID: 22057405 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up. Cossu G; Abbruzzese G; Matta G; Murgia D; Melis M; Ricchi V; Galanello R; Barella S; Origa R; Balocco M; Pelosin E; Marchese R; Ruffinengo U; Forni GL Parkinsonism Relat Disord; 2014 Jun; 20(6):651-4. PubMed ID: 24661465 [TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Bartzokis G; Sultzer D; Cummings J; Holt LE; Hance DB; Henderson VW; Mintz J Arch Gen Psychiatry; 2000 Jan; 57(1):47-53. PubMed ID: 10632232 [TBL] [Abstract][Full Text] [Related]
16. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Bartzokis G; Tishler TA Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological variability in neurodegeneration with brain iron accumulation. Vincze A; Kapás I; Molnar MJ; Kovács GG Ideggyogy Sz; 2010 Mar; 63(3-4):129-35. PubMed ID: 20405671 [TBL] [Abstract][Full Text] [Related]